(Q41905017)

reason for preferred rank

13 October 2017

title

Release of cholecystokinin from rat midbrain slices and modulatory effect of D2 DA receptor stimulation (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

28 October 2022

Release of cholecystokinin from rat midbrain slices and modulatory effect of D2DA receptor stimulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682000

28 October 2022

1 reference

3

S. I. Lentz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682000

28 October 2022

author name string

A. S. Freeman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682000

28 October 2022

L. A. Chiodo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682000

28 October 2022

K. Wade

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682000

28 October 2022

M. J. Bannon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682000

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1682000

28 October 2022

publication date

1 August 1991

1 reference

13 October 2017

2 August 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1682000

full work available at URL

28 October 2022

number of pages

7

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:000689939190353W?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

https://api.elsevier.com/content/article/PII:000689939190353W?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

28 October 2022

1 reference

13 October 2017

volume

555

1 reference

13 October 2017

issue

2

1 reference

13 October 2017

page(s)

281-287

1 reference

Dopamine ?Autoreceptors?: Pharmacological characterization by microiontophoretic single cell recording studies

13 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin

28 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Mesolimbic dopaminergic neurones and somatodendritic mechanisms

28 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Kainic acid inhibits cholecystokinin release from rat hippocampal slices

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Cholecystokinin potentiates dopamine inhibition of mesencephalic dopamine neurons in vitro

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Effects of selective dopamine D2-receptor agonists on the release of cholecystokinin-like immunoreactivity from rat neostriatum

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Cholecystokinin octapeptide: Vesicular localization and calcium dependent release from rat brain in vitro

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Cholecystokinin neuron systems and their interactions with the presynaptic features of the dopamine neuron systems. A morphometric and neurochemical analysis involving studies on the action of cholecystokinin-8 and cholecystokinin-58.

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Release of dopamine from dendrites in rat substantia nigra

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

The effects of cholecystokinin (CCK-8) on dopamine-containing nerve terminals in the caudate nucleus and nucleus accumbens of the anesthetized rat: an in vivo electrochemical study.

28 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

The regulation of cholecystokinin release from rat caudatoputamen in vitro

28 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

28 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Cholecystokinin-like peptides potentiate apomorphine-induced inhibition of dopamine neurons

28 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype.

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Release of endogenous norepinephrine and dopamine from rat brain regions in vitro

28 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens

28 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.

28 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

The localization and characterization of substance P and substance K in striatonigral neurons.

28 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Effect of cholecystokinin-octapeptide on dopamine release from slices of cat caudate nucleus

28 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Modulation of cholecystokinin release from posterior nucleus accumbens by D-2 dopamine receptor.

28 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Dopamine D1-receptor stimulation reduces neostriatal cholecystokinin release.

28 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Dopamine modulates cholecystokinin release in neostriatum.

28 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Release of dopamine in vivo from cat substantia nigra.

28 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum

28 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Amphetamine-induced release of dopamine from the substantia nigra in vitro

28 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Protection by serine peptidase inhibitors of endogenous cholecystokinin released from brain slices

28 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

The colocalization of cholecystokinin and tyrosine hydroxylase mRNAs in mesencephalic dopaminergic neurons in the rat brain examined byin situ hybridization

28 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions

28 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Forebrain projections from cholecystokininlike-immunoreactive neurons in the rat midbrain

28 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

A subpopulation of dopaminergic neurons in rat ventral mesencephalon contains both neurotensin and cholecystokinin

28 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studies using in situ hybridization combined with immunocytochemistry

28 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum

28 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Electrophysiologically identified nigral dopaminergic neurons intracellularly labeled with HRP: light-microscopic analysis

28 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Evidence that type A CCK receptors facilitate dopamine efflux in rat brain

28 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens

28 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin

28 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

The effects of cholecystokinin on the in vivo release of newly synthesized [3H]dopamine from the nucleus accumbens of the rat.

28 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Does cholecystokinin potentiate dopamine action in the nucleus accumbens?

28 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons

28 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90353-W

28 October 2022

Identifiers

1 reference

13 October 2017

1 reference